Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 7, 2008

Varian Pays $37M for Oxford Diffraction

  • Varian has taken ownership of Oxford Diffraction  for approximately $37 million in cash and assumed net debt. Oxford is a privately owned company based in Abingdon, U.K., that is focused on x-ray crystallography.

    The transaction also includes an opportunity for additional purchase price payments over three years, dependent on future financial performance. Those future payments could total up to $10 million if aggressive performance targets are achieved. Oxford Diffraction generated revenues of approximately $15 million for the twelve months ended March 31, 2008.

    "The acquisition of Oxford Diffraction is key to Varian's goal of broadening its range of information-rich detection products for life science research," says Garry W. Rogerson, president and CEO at Varian.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »